截至发稿，尚烁徽累计任职时间8年243天，现任基金资产总规模10.06亿元，任职期间最佳基金回报 135.67%， 任职期间最差基金回报-38.16%。 从基金十大重仓股角度 风险提示：市场有风险，投资需谨慎。本文为AI大模型自动发布，任何在本文出现的信息（包括但不 限于个股、评论、预测、图表、指标、理论、任何形式的表述等）均只作为参考，不构成个人投资建 议。 数据显示，华泰保兴基金旗下1只基金重仓百傲化学。华泰保兴产业升级混合发起A（021792）三季度 持有股数7万股，占基金净值比例为5.03%，位居第九大重仓股。根据测算，今日浮亏损失约11.9万元。 11月19日，百傲化学跌5%，截至发稿，报32.28元/股，成交4.40亿元，换手率1.89%，总市值227.97亿 元。 华泰保兴产业升级混合发起A（021792）成立日期2024年9月24日，最新规模1964.41万。今年以来收益 47.73%，同类排名940/8138；近一年收益45.09%，同类排名1126/8055；成立以来收益46.63%。 资料显示，大连百傲化学股份有限公司位于辽宁省大连市中山区港东街12号一方金融广场A座11楼，成 立日期2 ...

11月19日，百傲化学跌5%，截至发稿，报32.28元/股，成交4.41亿元，换手率1.89%，总市值227.97亿 元。 资料显示，大连百傲化学股份有限公司位于辽宁省大连市中山区港东街12号一方金融广场A座11楼，成 立日期2003年9月22日，上市日期2017年2月6日，公司主营业务涉及异噻唑啉酮类工业杀菌剂的研发、 生产和销售。主营业务收入构成为：工业杀菌剂54.95%，半导体44.36%，关键零部件及耗材0.23%，销 售副产品0.23%，其他0.22%。 从基金十大重仓股角度 数据显示，中银证券旗下1只基金重仓百傲化学。中银证券优选行业龙头混合A（009640）三季度增持 10.67万股，持有股数35.5万股，占基金净值比例为9.58%，位居第三大重仓股。根据测算，今日浮亏损 失约60.35万元。 中银证券优选行业龙头混合A（009640）成立日期2020年9月1日，最新规模6201.85万。今年以来收益 56.34%，同类排名499/8138；近一年收益53.56%，同类排名674/8055；成立以来亏损33.43%。 中银证券优选行业龙头混合A（009640）基金经理为宋方云。 截至发稿，宋方云 ...

Core Viewpoint - Baiao Chemical's stock has shown significant growth this year, with a year-to-date increase of 119.15%, indicating strong market performance and investor interest [1][2]. Financial Performance - For the period from January to September 2025, Baiao Chemical achieved a revenue of 1.056 billion yuan, representing a year-on-year growth of 17.88% [2]. - The net profit attributable to shareholders for the same period was 125 million yuan, which reflects a substantial decrease of 50.83% compared to the previous year [2]. Stock Market Activity - As of November 12, Baiao Chemical's stock price was 33.89 yuan per share, with a trading volume of 327 million yuan and a turnover rate of 1.40% [1]. - The company has appeared on the stock market's "Dragon and Tiger List" three times this year, with the most recent occurrence on August 28 [1]. Shareholder Information - As of September 30, the number of shareholders for Baiao Chemical increased by 12.51% to 24,000, while the average number of circulating shares per person decreased by 11.12% to 29,483 shares [2]. - The top ten circulating shareholders include significant institutional investors, with Hong Kong Central Clearing Limited holding 4.0587 million shares, an increase of 1.6304 million shares from the previous period [3]. Business Overview - Baiao Chemical, established on September 22, 2003, and listed on February 6, 2017, specializes in the research, production, and sales of isothiazolinone-based industrial biocides [1]. - The company's revenue composition includes 54.95% from industrial biocides and 44.36% from semiconductors, with minor contributions from other segments [1].

Core Viewpoint - Baiao Chemical's stock has shown significant growth this year, with a year-to-date increase of 108.74%, indicating strong market performance and investor interest [1][2]. Financial Performance - For the period from January to September 2025, Baiao Chemical achieved a revenue of 1.056 billion yuan, representing a year-on-year growth of 17.88% [2]. - The net profit attributable to shareholders for the same period was 125 million yuan, which reflects a substantial decrease of 50.83% compared to the previous year [2]. Stock Market Activity - As of November 11, Baiao Chemical's stock price was 32.28 yuan per share, with a market capitalization of 22.797 billion yuan [1]. - The stock has seen a trading volume of 1.16 billion yuan and a turnover rate of 0.51% on the same day [1]. - The stock has appeared on the "Dragon and Tiger List" three times this year, with the most recent appearance on August 28 [1]. Shareholder Information - As of September 30, 2025, the number of shareholders increased by 12.51% to 24,000, while the average circulating shares per person decreased by 11.12% to 29,483 shares [2][3]. - The top ten circulating shareholders include significant institutional investors, with Hong Kong Central Clearing Limited holding 4.0587 million shares, an increase of 1.6304 million shares from the previous period [3]. Dividend Distribution - Since its A-share listing, Baiao Chemical has distributed a total of 1.224 billion yuan in dividends, with 722 million yuan distributed over the past three years [3].

Group 1 - The core point of the news is that Baiao Chemical's stock price has dropped by 5.19%, currently trading at 31.26 CNY per share, with a total market capitalization of 22.077 billion CNY [1] - Baiao Chemical, established on September 22, 2003, and listed on February 6, 2017, specializes in the research, production, and sales of isothiazolinone industrial biocides [1] - The company's main business revenue composition includes industrial biocides at 54.95%, semiconductors at 44.36%, and other minor segments [1] Group 2 - According to data, a fund under Bank of China Securities has heavily invested in Baiao Chemical, with the fund increasing its holdings by 106,700 shares in the third quarter, bringing the total to 355,000 shares, which constitutes 9.58% of the fund's net value [2] - The fund, named Bank of China Securities Preferred Industry Leaders Mixed A (009640), has a total scale of 62.0185 million CNY and has achieved a year-to-date return of 60.17% [2] - The fund manager, Song Fangyun, has been in position for 2 years and 317 days, with the best fund return during this period being 22.23% and the worst being -39.29% [3]

Group 1 - The core point of the news is that Baiao Chemical's stock price has dropped by 5.19%, currently trading at 31.26 CNY per share, with a total market capitalization of 22.077 billion CNY [1] - Baiao Chemical, established on September 22, 2003, and listed on February 6, 2017, specializes in the research, production, and sales of isothiazolinone-based industrial biocides [1] - The company's main business revenue composition includes industrial biocides at 54.95%, semiconductors at 44.36%, key components and consumables at 0.23%, by-products at 0.23%, and others at 0.22% [1] Group 2 - From the perspective of fund holdings, Huatai Baoxing Fund has a significant position in Baiao Chemical, with its Huatai Baoxing Industrial Upgrade Mixed Fund A (021792) holding 70,000 shares, accounting for 5.03% of the fund's net value [2] - The fund has reported a floating loss of approximately 119,700 CNY as of the current date [2] - The Huatai Baoxing Industrial Upgrade Mixed Fund A was established on September 24, 2024, with a current scale of 19.6441 million CNY and has achieved a year-to-date return of 53.88% [2]

Group 1 - The core point of the news is that Baiao Chemical's stock price increased by 5.41% to 27.88 CNY per share, with a trading volume of 535 million CNY and a turnover rate of 2.85%, resulting in a total market capitalization of 19.69 billion CNY [1] - Baiao Chemical, established on September 22, 2003, and listed on February 6, 2017, specializes in the research, production, and sales of isothiazolinone industrial biocides [1] - The company's main business revenue composition includes industrial biocides at 54.95%, semiconductors at 44.36%, key components and consumables at 0.23%, sales of by-products at 0.23%, and others at 0.22% [1] Group 2 - Among Baiao Chemical's top ten circulating shareholders, a fund under Southern Fund, the Southern CSI 1000 ETF (512100), entered the top ten in the second quarter, holding 3.2711 million shares, which accounts for 0.46% of the circulating shares [2] - The Southern CSI 1000 ETF (512100) was established on September 29, 2016, with a latest scale of 64.953 billion CNY, achieving a year-to-date return of 29.81% and a one-year return of 34.98% [2] - The fund manager of Southern CSI 1000 ETF is Cui Lei, who has been in the position for 6 years and 339 days, with a total fund asset size of 94.976 billion CNY and a best fund return of 164.18% during the tenure [3]

Group 1 - The core viewpoint of the news is the performance and financial metrics of Baiao Chemical, which saw a stock price increase of 5.14% to 26.40 CNY per share, with a total market capitalization of 18.644 billion CNY [1] - Baiao Chemical's main business involves the research, production, and sales of isothiazolinone industrial biocides, with revenue composition being 54.95% from industrial biocides, 44.36% from semiconductors, and minor contributions from other segments [1] - The company is located in Dalian, Liaoning Province, and was established on September 22, 2003, with its listing date on February 6, 2017 [1] Group 2 - According to data from the top ten holdings of funds, a fund under Bank of China Securities has heavily invested in Baiao Chemical, increasing its holdings by 88,300 shares in the second quarter, making it the largest holding in the fund [2] - The fund, named Bank of China Securities Preferred Industry Leaders Mixed A (009640), has a net asset value proportion of 9.67% in Baiao Chemical, with an estimated floating profit of approximately 320,300 CNY [2] - The fund has shown significant performance with a year-to-date return of 63.29% and a one-year return of 91.28%, ranking 472 out of 8,173 and 864 out of 7,996 respectively [2]

Group 1 - The core viewpoint of the news is that Baiao Chemical's stock has increased by 5.14%, reaching a price of 26.40 CNY per share, with a trading volume of 209 million CNY and a turnover rate of 1.15%, resulting in a total market capitalization of 18.644 billion CNY [1] - Baiao Chemical, established on September 22, 2003, and listed on February 6, 2017, specializes in the research, production, and sales of isothiazolinone industrial biocides [1] - The company's main business revenue composition includes industrial biocides at 54.95%, semiconductors at 44.36%, key components and consumables at 0.23%, sales of by-products at 0.23%, and others at 0.22% [1] Group 2 - Among Baiao Chemical's top ten circulating shareholders, a fund under Southern Fund has entered the list, specifically the Southern CSI 1000 ETF (512100), which acquired 3.2711 million shares, accounting for 0.46% of the circulating shares [2] - The Southern CSI 1000 ETF (512100) was established on September 29, 2016, with a latest scale of 64.953 billion CNY, and has achieved a year-to-date return of 25.67% [2] - The fund has a one-year return of 67.42%, ranking 1298 out of 3814 in its category, and since its inception, it has returned 11.21% [2]

Group 1 - The core point of the news is that Baiao Chemical's stock price dropped by 5.01% to 25.58 CNY per share, with a trading volume of 494 million CNY and a turnover rate of 2.69%, resulting in a total market capitalization of 18.065 billion CNY [1] - Baiao Chemical, established on September 22, 2003, and listed on February 6, 2017, specializes in the research, production, and sales of isothiazolinone-based industrial biocides [1] - The company's main business revenue composition includes industrial biocides at 54.95%, semiconductors at 44.36%, key components and consumables at 0.23%, sales of by-products at 0.23%, and others at 0.22% [1] Group 2 - From the perspective of Baiao Chemical's top ten circulating shareholders, Southern Fund has a fund that ranks among the top shareholders, specifically the Southern CSI 1000 ETF (512100), which entered the top ten in the second quarter with 3.2711 million shares, accounting for 0.46% of circulating shares [2] - The estimated floating loss for the Southern CSI 1000 ETF today is approximately 4.416 million CNY [2] - The Southern CSI 1000 ETF was established on September 29, 2016, with a latest scale of 64.953 billion CNY, and has achieved a year-to-date return of 26.2% [2]